These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1760593)

  • 41. Homogeneous substrate-labeled fluorescent immunoassay for disopyramide in human serum: semi- and fully automated procedures.
    Johnson PK; Messenger LJ
    Clin Chem; 1986 Feb; 32(2):378-81. PubMed ID: 3510781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The determination of disopyramide in blood plasma and urine.
    Daniel JW; Subramanian G
    J Int Med Res; 1976; 4(1 Suppl):2-4. PubMed ID: 1026523
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison between two methods for the determination of the total and free (R)- and (S)-disopyramide in plasma using an alpha 1-acid glycoprotein column.
    Enquist M; Hermansson J
    J Chromatogr; 1989 Sep; 494():143-56. PubMed ID: 2584312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitive high-pressure liquid chromatographic determination of disopyramide and mono-N-dealkyldisopyramide.
    Nygard G; Shelver WH; Khalil SK
    J Pharm Sci; 1979 Oct; 68(10):1318-20. PubMed ID: 512870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Methods of assay of disopyramide in serum and urine (author's transl)].
    Mallein R; Boucherat M; Rondelet J; Pignat M; Ksavrelof H
    Ann Pharm Fr; 1978; 36(11-12):655-62. PubMed ID: 754645
    [No Abstract]   [Full Text] [Related]  

  • 46. Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein.
    Chen BH; Taylor EH; Pappas AA
    Clin Chim Acta; 1987 Feb; 163(1):75-80. PubMed ID: 3552331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicological screening in urine: comparison of two automated HPLC screening systems, toxicological identification system (TOX.I.S.*) versus REMEDI-HS.
    Schönberg L; Grobosch T; Lampe D; Kloft C
    J Anal Toxicol; 2007; 31(6):321-7. PubMed ID: 17725877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gas-chromatographic determination of disopyramide and its mono-N-dealkylated metabolite in serum with use of a nitrogen-selective detector.
    Bredesen JE
    Clin Chem; 1980 Apr; 26(5):638-40. PubMed ID: 7261311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automated liquid-chromatographic analyzer used for toxicology screening in a general hospital: 12 months' experience.
    Sadeg N; François G; Petit B; Dutertre-Catella H; Dumontet M
    Clin Chem; 1997 Mar; 43(3):498-504. PubMed ID: 9068594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous analysis of antiarrhythmic drugs and metabolites by high performance liquid chromatography: interference studies and comparisons with other methods.
    Wesley JF; Lasky FD
    Clin Biochem; 1982 Dec; 15(6):284-90. PubMed ID: 6762929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of caffeine plasma levels by an automated enzyme immunoassay (EMIT) in comparison with a high-performance liquid chromatographic method.
    Zysset T; Wahlländer A; Preisig R
    Ther Drug Monit; 1984; 6(3):348-54. PubMed ID: 6390797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of disopyramide and mono-N-desisopropyl-disopyramide in serum by gas-liquid chromatography with nitrogen-selective detection.
    Brien JF; Nakatsu K; Armstrong PW
    J Pharmacol Methods; 1983 Jun; 9(4):295-308. PubMed ID: 6621050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of tricyclic antidepressant plasma levels by an automated enzyme immunoassay (EMIT) in comparison to a high-performance liquid chromatographic method.
    Fazio A; Artesi C; Lorefice C; Oteri G; Romano F; Russo M; Spina E; Trio R; Pisani F
    Ther Drug Monit; 1988; 10(3):333-9. PubMed ID: 3051537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Saliva concentrations of disopyramide cannot substitute the drug's plasma concentrations.
    Cordonnier J; Van den Heede M; Heyndrickx A
    J Anal Toxicol; 1987; 11(4):179-81. PubMed ID: 3626531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring disopyramide, lidocaine, and quinidine by micellar liquid chromatography.
    Ochoa-Aranda E; Esteve-Romero J; Rambla-Alegre M; Martinavarro-Domínguez A; Bose D
    J AOAC Int; 2011; 94(2):537-42. PubMed ID: 21563688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gas-liquid chromatographic method for the routine estimation of disopyramide in plasma or serum.
    Johnston A; McHaffie D
    J Chromatogr; 1978 May; 152(2):501-6. PubMed ID: 659546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disopyramide and its N-monodesalkyl metabolite in breast milk.
    Barnett DB; Hudson SA; McBurney A
    Br J Clin Pharmacol; 1982 Aug; 14(2):310-2. PubMed ID: 7104189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An HPLC method for the simultaneous quantitation of quinidine, procainamide, N-acetylprocainamide, and disopyramide.
    Bridges RR; Jennison TA
    J Anal Toxicol; 1983; 7(2):65-8. PubMed ID: 6190040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Column-switching high-performance liquid chromatographic determination of vancomycin in serum.
    Demotes-Mainard F; Labat L; Vinçon G; Bannwarth B
    Ther Drug Monit; 1994 Jun; 16(3):293-7. PubMed ID: 8085283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of EMIT adapted to the (Cobas) Bio centrifugal analyzer.
    Oellerich M; Haeckel R; Haindl H
    J Clin Chem Clin Biochem; 1982 Oct; 20(10):765-72. PubMed ID: 6754852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.